Metabolic Syndrome in Patients with ST Elevated Myocardial Infarction

Introduction: ST-elevation myocardial infarction (STEMI) is a leading cause of morbidity and mortality worldwide. Present study is designed to gather data in our population about the prevalence of metabolic syndrome (MetS) in STEMI. The gathered data will help in better understanding of association of STEMI and metabolic syndrome. This will also help the physicians to devise preventive strategies based on life style modifications to limit further progression of this syndrome particularly in individuals who are at higher risk for CAD.

Objectives: To determine the frequency of metabolic syndrome in patients presented with ST segment elevated myocardial infarction.

Study design: Cross sectional study.

Duration of Study: 6 months (01-08-2018 to 31-01-2019)

Settings: Department of Cardiology, Pakistan Institute of Medical Sciences Islamabad

Subjects and Methods: A total of two hundred and fifty-seven (n=257) patients of both gender between age 18-75 years who were diagnosed cases of ST segment elevated myocardial infarction (STEMI) were enrolled in this study. Fasting blood sugar, Serum TG, HDL, blood pressure and waist circumference was estimated and frequency of metabolic syndrome was evaluated.

Results: Metabolic syndrome was found present in 37.4% (n=96/257) patients as per our operational definition. Frequency of metabolic syndrome was significantly higher in males as compared to females (P=0.048). No significant difference noted in the frequency of metabolic syndrome when data was stratified for different age groups (P=0.717).

Conclusions: Metabolic syndrome was observed to the highly prevalent among patients presented with ST segment elevated myocardial infarction and was significantly higher in males.